All Stories

  1. Acid-labile chemical bonds-based nanoparticles for endosome escape and intracellular delivery
  2. Recent advances in Fenton and Fenton-like reaction mediated nanoparticle in cancer therapy
  3. Fabricated technology of biomedical micro-nano hydrogel
  4. Nanoparticles-based phototherapy systems for cancer treatment: Current status and clinical potential
  5. Rational design of a polysaccharide-based viral mimicry nanocomplex for potent gene silencing in inflammatory tissues
  6. Controlled Interfacial Polymer Self‐Assembly Coordinates Ultrahigh Drug Loading and Zero‐Order Release in Particles Prepared under Continuous Flow
  7. A photoactive injectable antibacterial hydrogel to support chemo-immunotherapeutic effect of antigenic cell membrane and sorafenib by near-infrared light mediated tumor ablation
  8. Microfluidic preparation and optimization of sorafenib-loaded poly(ethylene glycol-block-caprolactone) nanoparticles for cancer therapy applications
  9. Nanostructured multifunctional stimuli-responsive glycopolypeptide-based copolymers for biomedical applications
  10. Porous Silicon Nanocarriers Boost the Immunomodulation of Mitochondria-Targeted Bovine Serum Albumins on Macrophage Polarization
  11. Recent approaches for enhancing the performance of dissolving microneedles in drug delivery applications
  12. Introduction to the RSC Advances themed collection on Nanomaterials in drug delivery
  13. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells (Adv. Healthcare Mater. 6/2023)
  14. Smart Nanoparticle‐based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy
  15. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells
  16. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect (Adv. Mater. 42/2022)
  17. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect
  18. Development of Surface Chemical Strategies for Synthesizing Redox‐Responsive Diatomite Nanoparticles as a Green Platform for On‐Demand Intracellular Release of an Antisense Peptide Nucleic Acid Anticancer Agent
  19. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform (Adv. Funct. Mater. 36/2022)
  20. Folic acid-mesoporous silicon nanoparticles enhance the anticancer activity of the p73-activating small molecule LEM2
  21. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform
  22. Microfluidics fabrication of micrometer‐sized hydrogels with precisely controlled geometries for biomedical applications
  23. Current trends in delivery of non-viral nucleic acid-based therapeutics for improved efficacy
  24. Autologous Skin Fibroblast‐Based PLGA Nanoparticles for Treating Multiorgan Fibrosis
  25. Molecular scale study on the interactions of biocompatible nanoparticles with macrophage membrane and blood proteins
  26. Mussel-Inspired and Bioclickable Peptide Engineered Surface to Combat Thrombosis and Infection
  27. Inhaled hydrogel-based microspheres for management of COVID-19: A new sweeper biological platform
  28. Progress in Stimuli‐Responsive Biomaterials for Treating Cardiovascular and Cerebrovascular Diseases
  29. Artificial Intelligence Deep Exploration of Influential Parameters on Physicochemical Properties of Curcumin‐Loaded Electrospun Nanofibers
  30. High drug-loaded microspheres enabled by controlled in-droplet precipitation promote functional recovery after spinal cord injury
  31. Functional biomaterials
  32. Neonatal Fc receptor-targeted lignin-encapsulated porous silicon nanoparticles for enhanced cellular interactions and insulin permeation across the intestinal epithelium
  33. Biomimetic platelet membrane-coated nanoparticles for targeted therapy
  34. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors (Adv. Mater. 9/2022)
  35. Surface Adsorption‐Mediated Ultrahigh Efficient Peptide Encapsulation with a Precise Ratiometric Control for Type 1 and 2 Diabetic Therapy
  36. Gelatin‐Lysozyme Nanofibrils Electrospun Patches with Improved Mechanical, Antioxidant and Bioresorbability Properties for Myocardial Regeneration Applications
  37. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors
  38. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
  39. Scaffold Vaccines for Generating Robust and Tunable Antibody Responses
  40. Synergistic immunomodulatory effect in macrophages mediated by magnetic nanoparticles modified with miRNAs
  41. Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells
  42. Emerging Theranostic Nanomaterials in Diabetes and Its Complications
  43. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds
  44. Inhibiting Phase Transfer of Protein Nanoparticles by Surface Camouflage–A Versatile and Efficient Protein Encapsulation Strategy
  45. In Vitro Evaluation of the Therapeutic Effects of Dual‐Drug Loaded Spermine‐Acetalated Dextran Nanoparticles Coated with Tannic Acid for Cardiac Applications
  46. Prospective Cancer Therapies Using Stimuli‐Responsive DNA Nanostructures
  47. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy (Adv. Mater. 40/2021)
  48. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy
  49. Programmable immune activating electrospun fibers for skin regeneration
  50. Nonresonant CARS Imaging of Porous and Solid Silicon Nanoparticles in Human Cells
  51. Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations
  52. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy
  53. Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery
  54. Quantitative Analysis of Porous Silicon Nanoparticles Functionalization by 1H NMR
  55. Engineering of 2D Materials To Trap And Kill SARS-CoV-2: A New Insight From Multi-Microsecond Atomistic Simulations
  56. Light‐Controlled Nanosystems: Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression (Adv. Funct. Mater. 27/2021)
  57. Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
  58. Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics
  59. Multistage signal-interactive nanoparticles improve tumor targeting through efficient nanoparticle-cell communications
  60. An organic-inorganic hybrid scaffold with honeycomb-like structures enabled by one-step self-assembly-driven electrospinning
  61. Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression
  62. A Theranostic Cellulose Nanocrystal‐Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma
  63. Mitochondria‐Targeted Bovine Serum Albumin@Copper Sulfide Nanocomposites Conjugated with Rhodamine‐110 Dye for an Enhanced Efficacy of Cancer Photothermal Therapy
  64. Chemically Engineered Immune Cell‐Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools
  65. DNA‐Grafted Hyaluronic Acid System with Enhanced Injectability and Biostability for Photo‐Controlled Osteoarthritis Gene Therapy
  66. LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy
  67. Synthesis and therapeutic potential of stimuli-responsive metal-organic frameworks
  68. One-step microfluidics production of enzyme-loaded liposomes for the treatment of inflammatory diseases
  69. Engineered Extracellular Vesicles for Cancer Therapy
  70. Development of vaccine formulations: past, present, and future
  71. Nanoparticle‐mediated siRNA delivery systems for cancer therapy
  72. Microneedles for painless transdermal immunotherapeutic applications
  73. Anti‐Bacterial Hydrogels: A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration (Adv. Healthcare Mater. 3/2021)
  74. Intraoperative Assessment and Photothermal Ablation of the Tumor Margins Using Gold Nanoparticles
  75. Correction: Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  76. Front cover
  77. Advanced Nanosystems for Clinical Translation
  78. Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics
  79. Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  80. Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds
  81. Conventional Nanosized Drug Delivery Systems for Cancer Applications
  82. Front Matter
  83. Introduction to lignocellulosic materials
  84. Requirements and properties of biomaterials for biomedical applications
  85. Bio-Nanomedicine for Cancer Therapy
  86. Combination Therapy of Killing Diseases by Injectable Hydrogels: From Concept to Medical Applications
  87. Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique
  88. Evaluation of the effects of nanoprecipitation process parameters on the size and morphology of poly(ethylene oxide)-block-polycaprolactone nanostructures
  89. Recent progress in the design of DNA vaccines against tuberculosis
  90. Cell–Nanoparticle Interactions: Toxicity and Safety Issues
  91. A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration
  92. One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease
  93. Requirements for Animal Experiments: Problems and Challenges
  94. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines
  95. 3D scaffolding of fast photocurable polyurethane for soft tissue engineering by stereolithography: Influence of materials and geometry on growth of fibroblast cells
  96. Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines
  97. Cell Membrane Wrapping: Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions (Adv. Healthcare Mater. 17/2020)
  98. Formulation optimization and in vitro characterization of rifampicin and ceftriaxone dual drug loaded niosomes with high energy probe sonication technique
  99. Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions
  100. Colorectal cancer triple co-culture spheroid model to assess the biocompatibility and anticancer properties of polymeric nanoparticles
  101. Multifunctional 3D‐Printed Patches for Long‐Term Drug Release Therapies after Myocardial Infarction
  102. Tandem‐Mass‐Tag Based Proteomic Analysis Facilitates Analyzing Critical Factors of Porous Silicon Nanoparticles in Determining Their Biological Responses under Diseased Condition
  103. Intracellular Delivery of Budesonide and Polydopamine Co‐Loaded in Endosomolytic Poly(butyl methacrylate‐ co ‐methacrylic acid) Grafted Acetalated Dextran for Macrophage Phenotype Switch from M1 to M2
  104. The Progress and Prospect of Zeolitic Imidazolate Frameworks in Cancer Therapy, Antibacterial Activity, and Biomineralization
  105. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery
  106. Microvascular Scaffolds: A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds (Adv. Sci. 9/2020)
  107. Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb
  108. Polyoxometalate Composites in Cancer Therapy and Diagnostics
  109. The solid progress of nanomedicine
  110. A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds
  111. Microfluidics: Microfluidics for Production of Particles: Mechanism, Methodology, and Applications (Small 9/2020)
  112. Gold–silver nanoshells promote wound healing from drug-resistant bacteria infection and enable monitoring via surface-enhanced Raman scattering imaging
  113. Recent trends on the development of systems for cancer diagnosis and treatment by microfluidic technology
  114. Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach
  115. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
  116. Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications
  117. Fabrication and Characterization of Drug-Loaded Conductive Poly(glycerol sebacate)/Nanoparticle-Based Composite Patch for Myocardial Infarction Applications
  118. Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications
  119. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency
  120. Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke
  121. Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction
  122. The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties
  123. Microfibers synthesized by wet-spinning of chitin nanomaterials: mechanical, structural and cell proliferation properties
  124. New insights into ethionamide metabolism: influence of oxidized methionine on its degradation path
  125. Hybrid red blood cell membrane coated porous silicon nanoparticles functionalized with cancer antigen induce depletion of T cells
  126. Novel RET agonist for the treatment of experimental neuropathies
  127. Oral drug delivery: Overview
  128. Spray-drying for the formulation of oral drug delivery systems
  129. All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery
  130. Mild temperature photothermal assisted anti-bacterial and anti-inflammatory nanosystem for synergistic treatment of post-cataract surgery endophthalmitis
  131. Superfast and controllable microfluidic inking of anti-inflammatory melanin-like nanoparticles inspired by cephalopods
  132. Gene‐Hydrogel Microenvironments: Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus (Adv. Sci. 1/2020)
  133. Osteogenic Hydrogels: Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration (Adv. Healthcare Mater. 1/2020)
  134. Cover Image
  135. Nanotechnology for Oral Drug Delivery
  136. Nanomedicine Therapies
  137. Handbook of In Vivo Chemistry in Mice
  138. Systematic in vitro biocompatibility studies of multimodal cellulose nanocrystal and lignin nanoparticles
  139. Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration
  140. Artificially cloaked viral nanovaccine for cancer immunotherapy
  141. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes
  142. Antitumor Therapeutics: A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics (Adv. Funct. Mater. 51/2019)
  143. Functionalized Bacterial Cellulose Microparticles for Drug Delivery in Biomedical Applications
  144. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting
  145. Microfluidics for Production of Particles: Mechanism, Methodology, and Applications
  146. Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus
  147. A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics
  148. Latest Advances on Bacterial Cellulose‐Based Materials for Wound Healing, Delivery Systems, and Tissue Engineering
  149. Landing a lethal blow on bacterial infections: an emerging advance of nanodots for wound healing acceleration
  150. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
  151. Antimicrobial Colloidal Silver–Lignin Particles via Ion and Solvent Exchange
  152. Metal Species–Encapsulated Mesoporous Silica Nanoparticles: Current Advancements and Latest Breakthroughs
  153. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  154. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  155. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
  156. On the issue of transparency and reproducibility in nanomedicine
  157. Self-Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  158. Acetalated Dextran Nanoparticles Loaded into an Injectable Alginate Cryogel for Combined Chemotherapy and Cancer Vaccination
  159. Microfluidics: Nuts and Bolts: Microfluidics for the Production of Biomaterials (Adv. Mater. Technol. 6/2019)
  160. Acetylated Nanocellulose for Single-Component Bioinks and Cell Proliferation on 3D-Printed Scaffolds
  161. Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor
  162. Preparation and Characterization of Dentin Phosphophoryn‐Derived Peptide‐Functionalized Lignin Nanoparticles for Enhanced Cellular Uptake
  163. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy
  164. Automatic methodologies to perform loading and release assays of anticancer drugs from mesoporous silicon nanoparticles
  165. Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes
  166. Photothermal-responsive nanosized hybrid polymersome as versatile therapeutics codelivery nanovehicle for effective tumor suppression
  167. Correction to “Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles”
  168. Porous Silicon as a Platform for Radiation Theranostics Together with a Novel RIB-Based Radiolanthanoid
  169. Self‐Healing: Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration (Adv. Sci. 3/2019)
  170. Metal-Based Stents: Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases (Adv. Mater. 8/2019)
  171. Nuts and Bolts: Microfluidics for the Production of Biomaterials
  172. Laser-Activatable CuS Nanodots to Treat Multidrug-Resistant Bacteria and Release Copper Ion to Accelerate Healing of Infected Chronic Nonhealing Wounds
  173. Outer–inner dual reinforced micro/nano hierarchical scaffolds for promoting osteogenesis
  174. Advanced Nanovaccines for Immunotherapy Applications: From Concept to Animal Tests
  175. Close-loop dynamic nanohybrids on collagen-ark with in situ gelling transformation capability for biomimetic stage-specific diabetic wound healing
  176. Microfluidic mixing and devices for preparing nanoparticulate drug delivery systems
  177. Photosensitive materials for constructing on-demanded drug-release systems
  178. Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles
  179. Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases
  180. Microfluidic Nanoassembly of Bioengineered Chitosan-Modified FcRn-Targeted Porous Silicon Nanoparticles @ Hypromellose Acetate Succinate for Oral Delivery of Antidiabetic Peptides
  181. Euryale Ferox Seed-Inspired Superlubricated Nanoparticles for Treatment of Osteoarthritis
  182. Adjustable hardness of hydrogel for promoting vascularization and maintaining stemness of stem cells in skin flap regeneration
  183. Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine
  184. Cellular Internalization-Induced Aggregation of Porous Silicon Nanoparticles for Ultrasound Imaging and Protein-Mediated Protection of Stem Cells
  185. Electrospun Fibrous Architectures for Drug Delivery, Tissue Engineering and Cancer Therapy
  186. Cell‐Nanoparticle Interactions at (Sub)–Nanometer Resolution Analyzed by Electron Microscopy and Correlative Coherent Anti‐Stokes Raman Scattering
  187. Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  188. Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications
  189. pH and Reactive Oxygen Species‐Sequential Responsive Nano‐in‐Micro Composite for Targeted Therapy of Inflammatory Bowel Disease
  190. Localized Controlled Delivery of Gemcitabine via Microsol Electrospun Fibers to Prevent Pancreatic Cancer Recurrence
  191. GDNF mimetics delivery by porous silicon nanoparticles for improved Parkinson’s disease management
  192. DNA Hydrogel Assemblies: Bridging Synthesis Principles to Biomedical Applications
  193. Light-Activatable Assembled Nanoparticles to Improve Tumor Penetration and Eradicate Metastasis in Triple Negative Breast Cancer
  194. Impact of Pore Size and Surface Chemistry of Porous Silicon Particles and Structure of Phospholipids on Their Interactions
  195. Materials Science in Finland
  196. Production of pure drug nanocrystals and nano co-crystals by confinement methods
  197. Materials Science in Finland: (Adv. Mater. 24/2018)
  198. Engineered Multifunctional Albumin-Decorated Porous Silicon Nanoparticles for FcRn Translocation of Insulin
  199. Mesoporous Silica Nanoparticles for Targeted and Stimuli-Responsive Delivery of Chemotherapeutics: A Review
  200. Sequential Antifouling Surface for Efficient Modulation of the Nanoparticle-Cell Interactions in Protein-Rich Environments
  201. Bioengineered Porous Silicon Nanoparticles@Macrophages Cell Membrane as Composite Platforms for Rheumatoid Arthritis
  202. Electrospun Polyhydroxybutyrate/Poly(ε-caprolactone)/Sol–Gel-Derived Silica Hybrid Scaffolds with Drug Releasing Function for Bone Tissue Engineering Applications
  203. Properties and chemical modifications of lignin: Towards lignin-based nanomaterials for biomedical applications
  204. Neuroprotection: Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity (Adv. Mater. 14/2018)
  205. Immunostimulation and Immunosuppression: Nanotechnology on the Brink
  206. Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4–NKX2-5 Interaction
  207. Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy
  208. The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems
  209. Current developments and applications of microfluidic technology toward clinical translation of nanomedicines
  210. Cell Membrane-Based Nanoreactor To Mimic the Bio-Compartmentalization Strategy of a Cell
  211. Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity
  212. Gold Nanorods Conjugated Porous Silicon Nanoparticles Encapsulated in Calcium Alginate Nano Hydrogels Using Microemulsion Templates
  213. Dual-Drug Delivery Using Dextran-Functionalized Nanoparticles Targeting Cardiac Fibroblasts for Cellular Reprogramming
  214. An immunological electrospun scaffold for tumor cell killing and healthy tissue regeneration
  215. Biofunctionalized Mesoporous Silica Nanomaterials for Targeted Drug Delivery
  216. Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration
  217. The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine
  218. 3D printing: prospects and challenges
  219. Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs
  220. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications
  221. Cancer Therapy: Nutlin‐3a and Cytokine Co‐loaded Spermine‐Modified Acetalated Dextran Nanoparticles for Cancer Chemo‐Immunotherapy (Adv. Funct. Mater. 42/2017)
  222. Manipulating Superparamagnetic Microparticles with an Electromagnetic Needle
  223. Multifunctional Nanohybrid Based on Porous Silicon Nanoparticles, Gold Nanoparticles, and Acetalated Dextran for Liver Regeneration and Acute Liver Failure Theranostics
  224. Fabrication of Calcium Phosphate-Based Nanocomposites Incorporating DNA Origami, Gold Nanorods, and Anticancer Drugs for Biomedical Applications
  225. Nutlin-3a and Cytokine Co-loaded Spermine-Modified Acetalated Dextran Nanoparticles for Cancer Chemo-Immunotherapy
  226. Non-invasive strategies for targeting the posterior segment of eye
  227. Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
  228. Protein Coating of DNA Nanostructures for Enhanced Stability and Immunocompatibility
  229. Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling
  230. Multifunctional Nanotube-Mucoadhesive Poly(methyl vinyl ether-co -maleic acid)@Hydroxypropyl Methylcellulose Acetate Succinate Composite for Site-Specific Oral Drug Delivery
  231. Photoluminescent Hybrids of Cellulose Nanocrystals and Carbon Quantum Dots as Cytocompatible Probes for in Vitro Bioimaging
  232. Coating Nanoparticles with Plant-Produced Transferrin–Hydrophobin Fusion Protein Enhances Their Uptake in Cancer Cells
  233. A multifunctional nanocomplex for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect
  234. Surface modification of acetaminophen particles by atomic layer deposition
  235. The impact of porous silicon nanoparticles on human cytochrome P450 metabolism in human liver microsomes in vitro
  236. Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines
  237. Insights into Caco-2 cell culture structure using coherent anti-Stokes Raman scattering (CARS) microscopy
  238. A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging
  239. Microfluidic Encapsulation of Prickly Zinc-Doped Copper Oxide Nanoparticles with VD1142 Modified Spermine Acetalated Dextran for Efficient Cancer Therapy
  240. Receptor-Mediated Surface Charge Inversion Platform Based on Porous Silicon Nanoparticles for Efficient Cancer Cell Recognition and Combination Therapy
  241. Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles
  242. Nanoreactors: Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions (Adv. Mater. 11/2017)
  243. Drug Delivery: A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals (Adv. Funct. Mater. 9/2017)
  244. In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells
  245. Preparation and biological evaluation of ethionamide-mesoporous silicon nanoparticles against Mycobacterium tuberculosis
  246. Nanovaccines: Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy (Adv. Mater. 7/2017)
  247. Fabrication, characterization and evaluation of bacterial cellulose-based capsule shells for oral drug delivery
  248. Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions
  249. A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals
  250. Core/Shell Nanocomposites Produced by Superfast Sequential Microfluidic Nanoprecipitation
  251. Cell Scaffolds: Electrospun Photocrosslinkable Hydrogel Fibrous Scaffolds for Rapid In Vivo Vascularized Skin Flap Regeneration (Adv. Funct. Mater. 2/2017)
  252. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy
  253. Microfluidic-assisted fabrication of carriers for controlled drug delivery
  254. Microfluidics platform for glass capillaries and its application in droplet and nanoparticle fabrication
  255. Springer Handbook of Nanotechnology
  256. Nano-Particles for Biomedical Applications
  257. Inside Cover Image, Volume 9, Issue 1
  258. Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy
  259. Quercetin-Based Modified Porous Silicon Nanoparticles for Enhanced Inhibition of Doxorubicin-Resistant Cancer Cells
  260. Drug Delivery: Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle-functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy (Adv. Mater. 46/2016)
  261. Microparticles to enhance delivery of drugs and growth factors into wound sites
  262. Active diffusion of nanoparticles of maternal origin within the embryonic brain
  263. Advances in biomedical and pharmaceutical applications of functional bacterial cellulose-based nanocomposites
  264. Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle‐functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy
  265. Enhanced Photoluminescence in Acetylene-Treated ZnO Nanorods
  266. Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells
  267. Microfluidics as a cutting-edge technique for drug delivery applications
  268. Targeted Cancer Therapy: pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin (Adv. Healthcare Mater. 15/2016)
  269. Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
  270. Antiproliferative Activity and Cellular Uptake of Evodiamine and Rutaecarpine Based on 3D Tumor Models
  271. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles
  272. Silica-Based Nanovectors: From Mother Nature to Biomedical Applications
  273. Applications of bacterial cellulose in food, cosmetics and drug delivery
  274. pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin
  275. Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model
  276. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin
  277. A comprehensive review of the neonatal Fc receptor and its application in drug delivery
  278. An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury
  279. Neovascularization: Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound (Adv. Healthcare Mater. 8/2016)
  280. Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound
  281. Functionalized nanoparticles for targeting the gastrointestinal apical membrane receptors
  282. Mesoporous Biomaterials: a Lexicon and Structured Bibliography of Reviews
  283. Chemotherapy with Porous Silicon
  284. In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
  285. Corrigendum to “Polymer-based nanoparticles for oral insulin delivery: Revisited approaches”,[Biotechnol Adv. 2015 Nov 1;33 (6 Pt 3):1342–54]
  286. Opinion Paper: Microfluidics Technique to Revolutionize the Drug Delivery Field: Current Developments and Applications
  287. Copolymers: Drug Delivery
  288. Controlled Shape and Nucleation Switching of Interfacially Polymerizable Nanoassemblies by Methyl Substitution
  289. Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure
  290. Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system
  291. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches
  292. Cyclodextrin-Modified Porous Silicon Nanoparticles for Efficient Sustained Drug Delivery and Proliferation Inhibition of Breast Cancer Cells
  293. Smart Porous Silicon Nanoparticles with Polymeric Coatings for Sequential Combination Therapy
  294. Multimodal non-linear optical imaging for the investigation of drug nano-/microcrystal–cell interactions
  295. Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs
  296. Simple Microfluidic Approach to Fabricate Monodisperse Hollow Microparticles for Multidrug Delivery
  297. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation
  298. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib
  299. Diatomite nanoparticles as potential drug delivery systems
  300. Inhibition of Multidrug Resistance of Cancer Cells by Co-Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes
  301. Microfluidics: A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties (Adv. Mater. 14/2015)
  302. Multifunctional porous silicon nanoparticles for cancer theranostics
  303. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy
  304. Drug Delivery: On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications (Adv. Funct. Mater. 10/2015)
  305. A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties
  306. Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration
  307. 3.5 Current Trends and Developments for Nanotechnology in Cancer
  308. On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications
  309. Functionalization of Alkyne-Terminated Thermally Hydrocarbonized Porous Silicon Nanoparticles With Targeting Peptides and Antifouling Polymers: Effect on the Human Plasma Protein Adsorption
  310. Mesoporous Biomaterials – multifunctional materials for future medical therapies and bioanalysis
  311. Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery
  312. Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy
  313. Solid state transformations in consequence of electrospraying – A novel polymorphic form of piroxicam
  314. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers
  315. A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors
  316. Revolutionary impact of nanovaccines on immunotherapy
  317. Coherent anti-Stokes Raman scattering microscopy driving the future of loaded mesoporous silica imaging
  318. In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications
  319. Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms
  320. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium
  321. Antihyperglycemic Potential of Incretins Orally Delivered via Nano and Microsystems and Subsequent Glucoregulatory Effects
  322. Targeting Membrane Transporters and Receptors as a mean to Optimize Orally Delivered Biotechnological based Drugs through Nanoparticle Delivery Systems
  323. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart
  324. Microfluidics-assisted engineering of polymeric microcapsules with high encapsulation efficiency for protein drug delivery
  325. Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering
  326. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers
  327. In Vivo Evaluation of Porous Silicon and Porous Silicon Solid Lipid Nanocomposites for Passive Targeting and Imaging
  328. Gene-based therapy for Type 1 diabetes mellitus: viral and nonviral vectors
  329. Fabrication of a Multifunctional Nano-in-micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix
  330. Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry
  331. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications
  332. Microfluidic Assembly of Monodisperse Multistage pH-Responsive Polymer/Porous Silicon Composites for Precisely Controlled Multi-Drug Delivery
  333. Confinement Effects on Drugs in Thermally Hydrocarbonized Porous Silicon
  334. Poly(methyl vinyl ether-alt-maleic acid)-Functionalized Porous Silicon Nanoparticles for Enhanced Stability and Cellular Internalization
  335. Mesoporous Materials and Nanocrystals for Enhancing the Dissolution Behavior of Poorly Water-soluble Drugs
  336. Microfluidic assembly of multistage porous silicon–lipid vesicles for controlled drug release
  337. Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors
  338. Biocompatibility of porous silicon for biomedical applications
  339. Copper-free azide–alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake
  340. Preface
  341. Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine
  342. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy
  343. Microfluidic Templated Mesoporous Silicon–Solid Lipid Microcomposites for Sustained Drug Delivery
  344. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility
  345. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles
  346. Inhibition of Influenza A Virus Infection in Vitro by Saliphenylhalamide-Loaded Porous Silicon Nanoparticles
  347. Drug delivery with nanostructured porous silicon nanoparticles
  348. Nanostructured Silicon-Based Materials as a Drug Delivery System for Water-Insoluble Drugs
  349. Metabolism of the Antituberculosis Drug Ethionamide
  350. Porous Silicon Nanoparticles
  351. Evaluation of the Physicochemical and Biopharmaceutical Properties of Fluoro-Indomethacin
  352. Editorial (Hot Topic: Non-Animal Models Used in Drug Discovery: Drug Absorption and Metabolism)
  353. Improving Oral Absorption Via Drug-Loaded Nanocarriers: Absorption Mechanisms, Intestinal Models and Rational Fabrication
  354. Encyclopedia of Metalloproteins
  355. Nanostructured Porous Silicon-Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release
  356. Oral Delivery of Glucagon-like Peptide-1 and Analogs: Alternatives for Diabetes Control?
  357. A new cocrystal and salts of itraconazole: Comparison of solid-state properties, stability and dissolution behavior
  358. Nanostructured porous Si-based nanoparticles for targeted drug delivery
  359. Porous-based biomaterials for tissue engineering and drug delivery applications
  360. Amine Modification of Thermally Carbonized Porous Silicon with Silane Coupling Chemistry
  361. Toxicological Profile of Therapeutic Nanodelivery Systems
  362. Nanostructured porous silicon materials: potential candidates for improving drug delivery
  363. Nanostructured porous silicon in preclinical imaging: Moving from bench to bedside
  364. New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles
  365. The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems
  366. Intravenous Delivery of Hydrophobin-Functionalized Porous Silicon Nanoparticles: Stability, Plasma Protein Adsorption and Biodistribution
  367. Cellular interactions of surface modified nanoporous silicon particles
  368. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles
  369. Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles
  370. 18F-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography
  371. Editorial [Hot Topic: Innovative Technologies for Drug Delivery Applications: From Biopolymers and Nanocapsules to Inorganic Materials (Guest Editor: Helder A. Santos)]
  372. Multifunctional Porous Silicon for Therapeutic Drug Delivery and Imaging
  373. 4th BBBB International Conference on Pharmaceutical Sciences
  374. Poster Presentation
  375. Drug Delivery Formulations of Ordered and Nonordered Mesoporous Silica: Comparison of Three Drug Loading Methods
  376. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole
  377. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles
  378. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
  379. Mesoporous materials as controlled drug delivery formulations
  380. In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size
  381. Long time effect on the stability of silver nanoparticles in aqueous medium: Effect of the synthesis and storage conditions
  382. Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats
  383. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells
  384. Electrochemical Properties of Phospholipid Monolayers at Liquid–Liquid Interfaces
  385. Biocompatibility of mesoporous silicon microparticles
  386. Drug dissolution studies on mesoporous silicon particles—A theoretical approach
  387. Failure of MTT as a Toxicity Testing Agent for Mesoporous Silicon Microparticles
  388. Thermodynamic analysis of binding between drugs and glycosaminoglycans by isothermal titration calorimetry and fluorescence spectroscopy
  389. Adsorption–Penetration Studies of Glucose Oxidase into Phospholipid Monolayers at the 1,2-Dichloroethane/Water Interface
  390. Cover Picture: Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface (ChemPhysChem 6/2007)
  391. Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface
  392. Analysis of adsorption of phospholipids at the 1,2-dichloroethane/water interface by electrochemical impedance spectroscopy: A study of the effect of the saturated alkyl chain
  393. Preparation of nanostructures composed of dextran sulfate/ruthenium nanoparticles and their interaction with phospholipid monolayers at a liquid–liquid interface
  394. Electrochemical Study of Interfacial Composite Nanostructures:  Polyelectrolyte/Gold Nanoparticle Multilayers Assembled on Phospholipid/Dextran Sulfate Monolayers at a Liquid−Liquid Interface
  395. Interfacial Interaction between Dextran Sulfate and Lipid Monolayers:  An Electrochemical Study†
  396. CHAPTER 9. Diatoms: A Natural Source of Nanostructured Silica for Drug Delivery